The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary safety, pharmacokinetics (PK), pharmacodynamics (PD) and clinical efficacy of uliledlimab (TJ004309), a differentiated CD73 antibody, in combination with atezolizumab in patients with advanced cancer.
 
Francisco Robert
Speakers' Bureau - Boehringer Ingelheim; Merck Sharp & Dohme; Takeda
Research Funding - Abbvie (Inst); Boehringer Ingelheim (Inst); Merck Sharp & Dohme (Inst); TRACON Pharma (Inst)
 
Ecaterina Elena Dumbrava
Consulting or Advisory Role - Bolt Biotherapeutics
 
Yan Xing
No Relationships to Disclose
 
Elizabeth Mills
No Relationships to Disclose
 
James L. Freddo
Employment - TRACON Pharma
Stock and Other Ownership Interests - BioCryst; Bristol-Myers Squibb; Gilead Sciences; Pfizer; Seagen; TRACON Pharma
Consulting or Advisory Role - Ignyta; TRACON Pharma
 
Charles P. Theuer
Employment - TRACON Pharma
Leadership - 4D Molecular Therapeutics; Oncternal Therapeutics, Inc; TRACON Pharma
Stock and Other Ownership Interests - 4D Molecular Therapeutics; Oncternal Therapeutics, Inc; TRACON Pharma
Consulting or Advisory Role - Singular Cure
Patents, Royalties, Other Intellectual Property - TRACON Pharma
 
Bonne J. Adams
Employment - TRACON Pharma
Stock and Other Ownership Interests - TRACON Pharma
Patents, Royalties, Other Intellectual Property - Methoxyamine HCL methods of use patent (TRC102 Tracon Pharmaceuticals)
 
James Lawrence
Employment - TRACON Pharma
Stock and Other Ownership Interests - AstraZeneca; GlaxoSmithKline; Isoray; TRACON Pharma
Consulting or Advisory Role - TRACON Pharma
 
Alicia A Trigeiro
Employment - TRACON Pharma
Stock and Other Ownership Interests - TRACON Pharma
 
Claire Xu
Employment - I-Mab
Stock and Other Ownership Interests - I-Mab
 
Yuan Meng
Employment - I-Mab
Stock and Other Ownership Interests - I-Mab
 
Linda Lee
Employment - I-Mab
 
Yonggang Zhao
Employment - I-Mab; Johnson & Johnson (I)
Stock and Other Ownership Interests - I-Mab; Johnson & Johnson (I)
 
Jerry Wang
Employment - I-Mab
Stock and Other Ownership Interests - I-Mab
 
Huaqiong Joan Shen
Employment - I-Mab
Leadership - I-Mab
Stock and Other Ownership Interests - I-Mab
 
Michael S. Gordon
Stock and Other Ownership Interests - BeckonCall; Caremission; WCCT Global
Consulting or Advisory Role - Agenus; Castle Biosciences; Daiichi Sankyo; Deciphera; Imaging Endpoints; Neon Therapeutics; RedHill Biopharma; Salarius Pharmaceuticals; TRACON Pharma
Research Funding - AADi (Inst); Abbvie (Inst); Acetylon Pharmaceuticals (Inst); Aduro Biotech (Inst); Advaxis (Inst); Agenus (Inst); Amal Therapeutics (Inst); Amgen (Inst); Arcus Biosciences (Inst); Array BioPharma (Inst); Astellas Pharma (Inst); Athenex (Inst); Ayala Pharmaceuticals (Inst); BeiGene (Inst); Beigene (Inst); BiolineRx (Inst); BioNTech (Inst); Blueprint Medicines (Inst); Calithera Biosciences (Inst); CanBas (Inst); cantex (Inst); Caris Centers of Excellence (Inst); Celgene (Inst); Celldex (Inst); Corcept Therapeutics (Inst); Corcept Therapeutics (Inst); CytomX Therapeutics (Inst); Deciphera (Inst); Driver Group (Inst); Endocyte (Inst); ESSA (Inst); FibroGen (Inst); Five Prime Therapeutics (Inst); Fujifilm (Inst); Fujifilm (Inst); Fujifilm (Inst); Genentech/Roche (Inst); Genocea Biosciences (Inst); Genzada Pharmaceuticals (Inst); Genzada Pharmaceuticals (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Halozyme (Inst); Helix BioPharma (Inst); Hengrui Therapeutics (Inst); IgM Biosciences (Inst); ImaginAb (Inst); ImmuneSensor Therapeutics (Inst); Inanovate (Inst); Incyte (Inst); Inhibrx (Inst); Lilly (Inst); Lilly/ImClone (Inst); MabVax (Inst); Macrogenics (Inst); MedImmune (Inst); Merck Serono (Inst); Merrimack (Inst); Millennium (Inst); Minneamrita Therapeutics (Inst); Molecular Partners (Inst); Nektar (Inst); Nektar (Inst); Neon Therapeutics (Inst); Neon Therapeutics (Inst); Novartis (Inst); Novartis (Inst); Novita Pharmaceuticals (Inst); OncoMed (Inst); Pfizer (Inst); Pfizer (Inst); Phoenix Biotech (Inst); Plexxikon (Inst); Proderm IQ (Inst); Revolution Medicines (Inst); Salarius Pharmaceuticals (Inst); Samumed (Inst); Seagen (Inst); Sirtex Medical (Inst); Strategia Therapeutics (Inst); Syndax (Inst); Syndax (Inst); SynDevRx (Inst); Syros Pharmaceuticals (Inst); tesaro (Inst); Tokai Pharmaceuticals (Inst); Tolero Pharmaceuticals (Inst); Toray Industries (Inst); TRACON Pharma (Inst); Trovagene (Inst); TTC Oncology (Inst); Verastem (Inst); Veru (Inst)
Patents, Royalties, Other Intellectual Property - Patient on patient selection for Clinical Trials